ZA96439B - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders - Google Patents

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders

Info

Publication number
ZA96439B
ZA96439B ZA96439A ZA96439A ZA96439B ZA 96439 B ZA96439 B ZA 96439B ZA 96439 A ZA96439 A ZA 96439A ZA 96439 A ZA96439 A ZA 96439A ZA 96439 B ZA96439 B ZA 96439B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
manufacture
treatment
pharmaceutical composition
degenerative disorders
Prior art date
Application number
ZA96439A
Inventor
Niels Korsgaard
Michael Shalmi
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA96439B publication Critical patent/ZA96439B/en

Links

ZA96439A 1995-01-20 1996-01-19 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders ZA96439B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK6895 1995-01-20

Publications (1)

Publication Number Publication Date
ZA96439B true ZA96439B (en) 1996-09-10

Family

ID=8089377

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96439A ZA96439B (en) 1995-01-20 1996-01-19 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders

Country Status (1)

Country Link
ZA (1) ZA96439B (en)

Similar Documents

Publication Publication Date Title
HUP9702244A3 (en) Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
IL121170A0 (en) Compositions for the treatment of dermatological disorders
HUP9904525A3 (en) Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan
AU8071894A (en) Compositions useful for the preparation of medicines for treating a variety of intractable disorders
AU4060599A (en) Pharmaceutical composition for treating or preventing sleep disorders
HUP9701193A3 (en) Use of n-(4-aryl-thiazol-2-yl)-sulfonamide derivatives for the preparation of pharmaceutical compositions treating neurological disorders, new derivatives, process for their preparation and pharmaceutical compositions containing them
IL124882A0 (en) Use of 3, 4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
HUP9702246A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of degenerative cerebral disorders
AU1367397A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HUP9800334A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
CA2260863A1 (en) Treatment of psychotic disorders
AU4329196A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
ZA96439B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders
AU4329096A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia
ZA98682B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
ZA98681B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibition senescense-associated motor impairment
ZA96440B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
AU3433797A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
ZA96446B (en) Use of 3,4-diphenyl chromans for the manufacture of pharmaceutical composition for the treatment or prophylaxis of obesity
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
ZA96248B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia
AU2245695A (en) Composition for treating neurological disorders
ZA97170B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms.
IL126276A0 (en) The use of an inhibitor of the na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system